BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 11388739)

  • 21. [Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches].
    Spiekermann K; Hiddemann W; Schnittger S
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1020-5. PubMed ID: 15830315
    [No Abstract]   [Full Text] [Related]  

  • 22. Normal and oncogenic FLT3.
    Naoe T; Kiyoi H
    Cell Mol Life Sci; 2004 Dec; 61(23):2932-8. PubMed ID: 15583855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiology and treatment of acute myeloid leukemia].
    Naoe J
    Rinsho Ketsueki; 2003 Apr; 44(4):219-26. PubMed ID: 12784654
    [No Abstract]   [Full Text] [Related]  

  • 24. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
    Lyman SD; Brasel K; Rousseau AM; Williams DE
    Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FLT-3: a new focus in the understanding of acute leukemia.
    Markovic A; MacKenzie KL; Lock RB
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1168-72. PubMed ID: 15778081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical localization of receptor protein kinases in plants.
    Counihan VP; Phillips TE; Walker JC
    Methods Cell Biol; 1995; 49():515-29. PubMed ID: 8531781
    [No Abstract]   [Full Text] [Related]  

  • 27. CD135.
    Del Zotto G; Luchetti F; Zamai L
    J Biol Regul Homeost Agents; 2001; 15(1):103-6. PubMed ID: 11388739
    [No Abstract]   [Full Text] [Related]  

  • 28. [FLT3/FLK2: a novel member of tyrosine kinase receptor family].
    Wen GY; He FC; Su ZZ
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):165-7. PubMed ID: 9592244
    [No Abstract]   [Full Text] [Related]  

  • 29. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor angiogenesis and Flt tyrosine kinase].
    Shibuya M
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1470-6. PubMed ID: 9279070
    [No Abstract]   [Full Text] [Related]  

  • 31. Hematopoietic receptors of class III receptor-type tyrosine kinases.
    Rosnet O; Birnbaum D
    Crit Rev Oncog; 1993; 4(6):595-613. PubMed ID: 7506935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product.
    Rubin JS; Bottaro DP; Aaronson SA
    Biochim Biophys Acta; 1993 Dec; 1155(3):357-71. PubMed ID: 8268192
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.